Accellix Announces the Appointment of Charles Piazza to its Board of Directors

SAN JOSE, Calif.–(BUSINESS WIRE)–#Accellix–Accellix Inc. announces the appointment of a new Board Member, Mr. Charles Piazza. Charles (Chuck) Piazza, Accellix’s newest board member, has over 35 years of global experience within the life science industry serving the pharmaceutical, biotechnology and medical research sectors. His recent positions included Vice President and General Manager for the Molecular Biology Research products division of Life Technologies (now part of Thermo Fisher) and Vice President for Global Sales Operations and Pricing.

Chuck commented, “In the pursuit of new and efficacious therapies, one must adhere to the strictest set of analytical methods. Cells that are undergoing different processes that turn them into potential therapeutic tools, need to be tested swiftly and reproducibly. That’s what attracted me to the Accellix mission. I intend to help Accellix’s management pursue this mission and am confident we will succeed in doing so.”

Nir Nimrodi, Accellix’s Executive Chairman said, “I have known Chuck for more than a decade and have seen him lead and grow businesses in the life science tools industry. He did it with intelligence, intense focus and unwavering relentlessness. I had the privilege to professionally benefit from working with him and am looking forward to his contributions to our company and team.”

Prior to joining Life Technologies (ThermoFisher), Chuck was Vice President and General Manager for molecular biology tools at Cambrex BioSciences (now part of Lonza), a supplier of molecular biology and cell culture products, including normal human and hematopoietic stem cells. Earlier in his career, Chuck also served as the Director of Sales and Marketing at FMC BioProducts, a life science reagents division of FMC Corporation.

Accellix Inc. provides assay migration and a delivery platform for on demand process analytics. The Accellix System is an assay delivery platform that provides quick, reliable, flow cytometry with multi-parameter results using a small instrument and room temperature stable cartridge. The Accellix platform offers simplicity of use, flexibility and automated data analysis.

Contacts

Rey Mali

[email protected]

www.accellix.com